Oncolytics Biotech Inc (ONCY) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ONCY Annual Balance Sheets →
Examining balance sheet movements between Oncolytics Biotech Inc and 0 reveals how Jun 30 2026 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Dec 31 2024) 0
Assets
Cash & cash equivalent4.12
Cash And Cash Equivalents0.00
Cash & Short-term Investments4.00
Other Receivables, Net, Current1.21
Notes Receivable, Current1.18
Other Current Assets0.00
Prepaid Expense, Current AS1.74
Total Current Assets7.07
Equipment/Property/Plant Net0.20
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.40
Operating Lease Right Of Use Asset0.46
Total Assets7.67
Liabilities
Accounts Payable, Current AC3.41
Accrued Liabilities, Current AC1.68
Derivative Liability, Current DE0.00
Other Liabilities, Current0.14
Total Current Liabilities5.23
Total Long-term Debt0.00
Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent DE3.39
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent5.22
OperatingLeaseLiabilityNoncurrent0.34
Operating Lease Liability Current0.17
Total Liabilities13.84
Stockholders' Equity
Additional Paid In Capital Common Stock435.79
Retained Earnings / Accumulated Deficit-448.18
Accumulated Other Comprehensive Income6.23
Defined Benefit Plan and Other0.00
Other Equity6.23
Common Stockholder's Equity-6.17
Total Stockholder's Equity-6.17
Liabilities & Stockholder's Equity7.67
4 historic quarters locked

Sign in to unlock the full Oncolytics Biotech Inc balance sheet history.

About Oncolytics Biotech Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001129928-26-000051

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.